Resonance Health LtdASX: RHT

$6.0 Million Placement Oversubscribed

· Issued by Resonance Health Ltd via ASX

Filed with ASX · · 4 pages · English

Summary by 6ix AI

Resonance Health Ltd has announced the completion of an oversubscribed placement to raise funds from institutional investors, significantly strengthening its balance sheet. The placement will fully fund three growth programs over the next two years, focusing on clinical trials related to metabolic and obesity treatments. The company reported a substantial increase in net cash, which will support its operational and strategic initiatives moving forward. This announcement highlights the company's profitable performance and positive cash flow, reinforcing investor confidence in its growth strategy.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX Announcement – 27 October 2026 $6.0 MILLION PLACEMENT OVERSUBSCRIBED BALANCE SHEET STRENGTHENED TO FUND THREE GROWTH PROGRAMMES Highlights • Firm commitments received for a $6.0M placement to institutional, professional + sophisticated investors at 7.2 cents per share, a 6.4% discount to...

Resonance Health Ltd on 6ix

Earlier from Resonance Health

Later from Resonance Health

All Resonance Health news releases